Recent data suggest that short-term subcutaneous insulin administration delays but does not prevent diabetes in NOD mice, likely by inducing a state of ‘β-cell rest' that would make β cells less vulnerable to metabolic stress, apoptosis and possibly to immune-mediated destruction49, 51. This evidence concerns the gene INS and diabetes mellitus.